Detectivio Joins NVIDIA Inception

Detectivio today announced that the company is a part of NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in AI and data science.

NVIDIA supplies the global market with graphics processors and chipsets for motherboards. NVIDIA Inception helps startups during critical stages of product development, prototyping, and deployment. Each member receives marketing support, technology assistance and other benefits to help the startup develop and grow.

“By joining NVIDIA Inception, we get the opportunity drive business forward with expert support in AI software and GPU-based computing technology,“ says Stefan Malmberg, founder and CEO of Detectivio. “It is a good opportunity for Detectivio to develop our AI-based method of measuring human vital signs. NVIDIA Inception also allows us to collaborate with industry-leading experts and other AI-driven organizations.”

Detectivio's membership in NVIDIA Inception fosters further engagement with companies developing new AI-based products with a healthcare focus. Detectivio is interested in the NVIDIA Clara AGX developer kit, which is adapted to securely manage and organize AI applications for data collection in medical devices.

For more information:
Stefan Malmberg, stefan@detectivio.com, 0730-758004

In 2017, a doctor and a system scientist founded Detectivio and thus began a mission with advanced sensors, optics, digital signal processing, computer vision, machine learning and artificial neural networks. All to use modern technology to facilitate and streamline the measurement of vital signs – the basis for assessing health. A first study is in the final phase with promising preliminary results and in autumn 2021 a larger clinical study is planned within the Västra Götaland region. With the support of Sahlgrenska Science Park, Detectivio continues to develop to be able to realize its product.  http://www.detectivio.com